UnitedHealth, Humana, CVS Shares Plunge as Trump Administration Proposes Lower-Than-Expected Medicare Insurer Rates
By Adam Eckert
January 27, 2026
Shares of major health insurers UnitedHealth Group (UNH), Humana (HUM), and CVS Health (CVS) experienced significant declines after market close on Monday, reacting to news about the Trump administration’s upcoming proposal regarding Medicare insurer rates for 2027. According to a report from The Wall Street Journal, officials from the Centers for Medicare and Medicaid Services (CMS) and the White House indicated that the administration plans to set Medicare Advantage payment rates that are essentially unchanged from previous levels. The proposal would increase plan payments by approximately just 0.09% for the next year, far below many investors’ expectations for a more robust hike.
This slower growth in Medicare insurer reimbursements has broad implications for companies heavily involved in the Medicare Advantage program, including UnitedHealth, Humana, and CVS, all of whom derive a considerable portion of their revenue from these plans. Investors reacted swiftly, with Humana’s stock falling by over 21%, UnitedHealth’s shares dropping nearly 20%, and CVS shares declining more than 14% shortly after the news broke.
The anticipated official announcement from CMS regarding the 2027 Medicare Advantage plan payment rates is expected later Monday, solidifying the administration’s position on healthcare spending and insurer reimbursements under Medicare.
Market analysts suggest that the modest rate adjustment will likely pressure insurer profitability and could lead to strategic reassessments within the sector. The response from investors underscores the sensitivity of health insurer stocks to federal policy decisions, especially those impacting Medicare Advantage, a rapidly growing segment of the U.S. health insurance market.
As Medicare remains a critical component of the American healthcare system, these proposed payment rates will be closely monitored by industry stakeholders, policy experts, and market participants in the coming days.
This article will be updated as more details become available.